Digital Pharma
Follow
Find
15.6K views | +0 today
Digital Pharma
All about digital in the pharmaceutical industry
Your new post is loading...
Your new post is loading...
Scooped by Thibaud Guymard
Scoop.it!

It helps when patients get the message

It helps when patients get the message | Digital Pharma | Scoop.it
THE problem with new communications technology is that "everybody wants to do something cool", says Rebekah Russell-Bennett, associate professor of advertising, marketing and public relations at the Queensland University of Technology.

And what that means right now in health care is that everybody wants an iPhone app.

Apps are undeniably cool, and there are already lots of health-based apps around. "But there are barriers to using an iPhone, not least the fact that lots of people don't have one," continues Russell-Bennett. "And why overdo something? You really just need a tool that will work."
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

What does the future of mHealth seem like to you? Future of mHealth through the eyes of last week’s FDA draft guidance

What does the future of mHealth seem like to you? Future of mHealth through the eyes of last week’s FDA draft guidance | Digital Pharma | Scoop.it
Although the issuance of draft guidance for mobile medical applications by the FDA on July 19th came as a surprise to many, experts close to the field have sensed that this summer would prove to be an important and pivotal period for the mHealth regulatory scheme. In fact, the independent mHealth Regulatory Coalition has been working steadily and in parallel with the FDA to issue their own draft guidance recommendations, while Bradley Thompson, a medical device attorney and regulatory expert with Epstein Becker Green has been publicly sharing his analysis and predictions regarding mHealth regulation for quite some time.

Now that the FDA draft guidance has been released, what does it mean for the future of mHealth and its potential for pharma? Will the Wild Wild West of mHealth medical apps finally be corralled for the safety of patients and the protection of physicians? What will the new regulatory environment cost mHealth in terms of slowed innovation, increased barriers of entry, and the active involvement of an already over-extended governmental agency? And how will this draft guidance, presumably soon to be finalized and made binding, ultimately impact the mHealth industry?
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Social Media in the Pharmaceutical Industry

Recently, I was a delegate at the SMi Social Media in the Pharmaceutical Industry conference in London.


The role of social media, and more widely, digital media, in healthcare was explored from a number of perspectives during the conference.

It was clear that emerging channels could bring great benefits to patients and the NHS. For example, as described by Carl Plant in his presentation on NHS Local (a range of digital services for people inthe UK’s West Midlands) , engaging digitally with patients could provide inputs to service design, as well as valuable feedback on service quality and accessibility. When patients are able to influence how care is delivered, it is likely that the outcome is a better-targeted healthcare system, with more efficient use of financial resources...
more...
No comment yet.
Rescooped by Thibaud Guymard from Pharma
Scoop.it!

Digital Pharma: iPhone and iPad app update

Digital Pharma: iPhone and iPad app update | Digital Pharma | Scoop.it
Dominc Tyer (@Dominic_Tyer) asks:

Which Pharma company has just launched the first non-European language iPhone app? (illustrated; smoking cessation support)
How many iPads has Boehringer Ingelheim ordered for its sales force in Turkey?
Do Novartis’ investors really want their annual reports in iPad app form?
Does Abbott think QR codes are the future?

Those are some of the questions posed by pharma’s latest batch of mobile apps, as the industry’s Apple-focused interest in mobile devices continues apace.
Via Andrew Spong
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Beyond technology: how pharma marketing will be transformed...

Beyond technology: how pharma marketing will be transformed... | Digital Pharma | Scoop.it
I speak about social media and pharma company communications all the time.

I find myself talking about it not just for my day to day job, or when speaking at various conferences and meetings around the world - I even talk about it when relaxing with friends or visiting my parents. I am, in short, obsessed.

It is strange then that I found writing this article very difficult. Since you’re reading this, I managed it in the end of course, but the effort surprised me and I think this is for two primary reasons.

Firstly, this is a massive and extremely complex subject, constantly moving on shifting sands and wreaking havoc in many industries.

That makes it difficult to distil into an easily digestible article.

Secondly, it has become almost impossible to write about social/new media without falling into cliché.

Even the terms....
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Lessons from Google Health

Lessons from Google Health | Digital Pharma | Scoop.it
As Google announced the end of Google Health last week, a little over three years since its launch in May 2008 promised to revolutionise health records management, thousands of health consumers might well have wondered what this means for the future of their personal electronic health records.

The answer to that, says Google, is that they can download their records for use elsewhere. Google says that it is ending Google Health because of a lack of adoption by users. In the blog post, Aaron Brown, Senior Product Manager, Google Health says:

“When we launched Google Health, our goal was to create a service that would give people access to their personal health and wellness information. We wanted to translate our successful consumer-centered approach from other domains to healthcare and have a real impact on the day-to-day health experiences of millions of our users...
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Is failure an option? Assessing risk when everything keeps changing

Is failure an option? Assessing risk when everything keeps changing | Digital Pharma | Scoop.it
No one wants to be wrong; ever. As much as there are trendy business mantras such as ‘Fail Fast’ which apparently encourage failure (as long as you learn quickly), it somehow just doesn’t translate to the world of a pharmaceutical company. In fact, ‘fail-fast’ is really an engineering concept that is most often considered in a research and development phase, long before a product reaches the general public where it might affect reputation.

To be fair, any kind of ‘failure’ in the world of pharmaceutical companies can potentially result in a significant loss in some form or another which could include shareholder value, customer confidence, or general credibility, not to mention individual careers...
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Guidance notes on the management of adverse events and product complaints from pharmaceutical company sponsored websites - ABPI

Guidance notes on the management of adverse events and product complaints from pharmaceutical company sponsored websites - ABPI | Digital Pharma | Scoop.it
The ABPI Pharmacovigilance Expert Network (PEN) recognises the value of using social media to communicate externally with customers. Despite the obvious benefits of using social media, there are regulatory and legal considerations due to the inherent nature of this channel. Attention to company values, legal and policy requirements are necessary for successful participation in the social media environment. These guidance notes provide suggested best practices for the monitoring and management of adverse events (AEs) and product complaints (PCs) from social media use in company sponsored websites. They have been developed by the ABPI and shared with the Medicines and Healthcare Products Regulatory Agency (MHRA).
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

A Clinical Drug Trial Via Smartphone, Computer

Pfizer Inc. is conducting a drug trial in which patients participate from their homes using computers and smartphones rather than visiting a clinic.

The company plans to compare the results to those obtained from a previous, traditional trial of the same drug. The study involves the company's overactive-bladder drug Detrol.

If successful, the methods used in the study might eventually be used to help drive down the high cost of bringing new medicines to market.

The Food and Drug Administration recently signed off on Pfizer's study, which is believed to be the first all-electronic, home-based study of a drug to receive agency approval.
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Making community health information as useful as weather data

Making community health information as useful as weather data | Digital Pharma | Scoop.it
The chief technology office of Health and Human Services, Todd Park, is fond of using the National Ocean and Oceanographic Association as a metaphor for the innovation that may be unlocked through releasing public data.
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Startup Hopes to Make Sickness Social

Startup Hopes to Make Sickness Social | Digital Pharma | Scoop.it
If a close friend has a cold, chances are you might catch it. A startup called Sickweather hopes to tap into the social side of sickness with a social networking service that tracks illnesses within a user's circle of friends, and to forecast outbreaks.

The startup mines publicly available data from social networks such as Twitter and Facebook, as well as from its users, to provide information on illness trends. Sickweather recently launched an early version of its site for closed beta testing, and plans to open to a broader audience in July.

While some people complain about the vast quantities of often mundane data uploaded to social networks every day,...
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Digital Marketing in Japanese Pharma: Special Report

Digital Marketing in Japanese Pharma: Special Report | Digital Pharma | Scoop.it
A detailed analysis of the research is now available to download free of charge, in both Japanese and English languages. The report provides insights into the evolution of the relationship between patients and physicians in Japan; reveals the key challenges and opportunities faced by Japanese pharmaceutical marketers; and provides a glimpse into which channels will be prioritised in future budget plans. Also included is the result of a poll into the most admired pharmaceutical companies for their effective use of social media in Japan, as ranked by their peers.

Download the full report now.
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Building trust with empowered patients

In the second of a series of videos, various thought-leaders from around the world contribute insights about building trust with empowered patients.

Creation Healthcare attended events in New York, London, and Munich in the early part of 2011, and asked the global elite forum about the key issues affecting healthcare engagement, based on their experience.

This episode features some of these thoughts about how to build effective relationships with empowered patients (or e-Patients), and the types of information provision that can meet their needs in a mutually beneficial way.
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Pharma communication in a multi-regulatory world

Pharma communication in a multi-regulatory world | Digital Pharma | Scoop.it
Few could have predicted the way in which the Internet has changed the dynamic of relationships amongst healthcare stakeholders. For the pharmaceutical industry, it seems there is an opportunity to also play a role in the many online relationships which are made possible by the Internet.

Despite the Internet being completely global and respecting none of our historical or legal boundaries, the differing regulatory systems present a very polarised approach to pharmaceutical communication.

Therein is a challenge and an opportunity, to find the perfect balance which allows a pharmaceutical company to provide appropriate information to the right people at the right time, and of course in the right way.
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Will new channels change your strategy?

Will new channels change your strategy? | Digital Pharma | Scoop.it
Many articles have been written in recent weeks about the trend of the moment: Google Plus. Whenever a new platform or technology comes out, many predictions about its future are made. But do you trust predictions?

Actually, it is interesting to read what people think about it because it helps us make our own decision on whether we want to get involved with a new platform or not, or simply to know more about it. I read people writing that Google+ is a revolution; others talk about an evolution, a competitor to Facebook, a “place to be” for companies, a useless + tool, or even that we will no longer see new web 2.0 platforms after Google’s one (or they will be copies).

Anyway, my point is that all this information can obviously be valuable for marketers and communicators in order to stay informed, but all this noise might distract your attention from the real insights.

Social media platforms don’t matter but your stakeholders do.

Google+, like other technology trends, may provide opportunities for you or your business to improve what you are already doing or do to new things in order to achieve better results. However, the Internet is constantly moving, new territories appear and disappear every day but one thing never changes: who your care about, the various healthcare stakeholders...
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

FDA guidance exempts most pharma apps from scrutiny

FDA guidance exempts most pharma apps from scrutiny | Digital Pharma | Scoop.it

FDA issued draft guidance on mobile medical apps, focusing narrowly on those programs that augment regulated medical devices or turn mobile devices into medical devices.



The agency signaled that it will prioritize concern for the functionality of such devices – for example, whether a mobile device's screen size and lower contrast ratio might compromise a radiological imaging app – and safeguarding patient information. And it laid out specific definitions, along with examples, of what it considers to be a “mobile platform,” a “mobile application” and a “mobile medical app,” which “is used as an accessory to a regulated medical device; or transforms a mobile platform into a regulated medical device.”


For pharmas and their agencies...
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Member dominating Facebook page: What would you do?

Member dominating Facebook page: What would you do? | Digital Pharma | Scoop.it
Reading the community manager’s responses, I felt her actions were spot on. She listened and actively monitored. Her posts

were respectful and did not flame the discussion
gave the 2 people options to legitimize their claims
did not discredit their right to their opinion
helped correct misconceptions for other readers
Most importantly, she allowed other members to police the community. The last post claiming the cure for cancer included 29 comments from other members, illustrating their intelligence and grace. Ultimately the community organically shut down the 2 people and they stopped posting.

What about using pro-active tactics to increase activity? For example...
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

What will Google+ mean for healthcare

What will Google+ mean for healthcare | Digital Pharma | Scoop.it
(My answer: nothing yet...wait, listen and learn)

In continuing to roll out its Facebook-like social media-based offerings, internet search giant Google has launched a beta version of a new service called Google+, which strives to improve individual searches and allow users to connect on similar topics. Google+ currently offers four key tools to users: Circles, for connecting socially with friends; Sparks, which offers a search engine-link tool for sharing content based on interest; Hangouts, for group video chat; and Huddle, for group messaging...
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Language & culture: Two keys to global digital engagement strategy

Language & culture: Two keys to global digital engagement strategy | Digital Pharma | Scoop.it
In recent years, global digital engagement strategies have become critical for pharmaceutical companies operating all around the world. Global strategies need to fit each company’s culture, vision and purpose as well as their specific brands’ characteristics. And whilst digital channels have changed much about the dynamics of communication, digital engagement must be aligned with how the company already interacts with their stakeholders and its overall brand values.

Local insights for global success

Global strategies mean...
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

The Data Economy: How Social Networking Is Changing the Health Care Industry

With data collection and the new forms that data is taking on, and the ways that new data needs to be disseminated, a new paradigm for health can be created.
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Digital Pharma: European doctors turn to the social web

Digital Pharma: European doctors turn to the social web | Digital Pharma | Scoop.it
European GPs are making increasing use of the social web and new research has shown Wikipedia to be the most popular destination there.

Now ten years old, the online collaborative encyclopaedia is the world’s fifth most popular website, attracting more than 400 million visitors each month, and its accuracy, if not readability, has been praised in several studies.

Insight Research Group surveyed 300 primary care doctors in the first quarter of this year, drawing equal numbers from Germany, Italy and the UK.

The agency found 69% of physicians said they used some form of social media for work, and 60% said they used Wikipedia professionally.

After Wikipedia, the most popular sites were YouTube (used professionally by 18% of respondents), Facebook (5.7%), LinkedIn (4.7%) and Twitter (1.3%).
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Doctors using tablet-based EMRs like portability, productivity and patient communication

Doctors using tablet-based EMRs like portability, productivity and patient communication | Digital Pharma | Scoop.it
The dramatic growth of tablets, and especially iPads, among physicians tells an important story about design, usability, and productivity. Physicians have quickly cottoned onto this particular mobile device because those who use find it increases professional productivity because it’s portable, intuitive to learn, and fast. Furthermore, tablet-using physicians say they like how it enhances patient-physician communication.

Doctors tethered to a paper chart or desktop computer can’t easily break their eyes away to visually engage with a patient during an exam. Something about the iPad, physicians find, opens up communication with patients. This can bolster greater trust and health literacy, opening up communication channels between patient and provider. This is a prerequisite for connected health. It’s not about the device itself — which is indeed beloved among its adopters. It’s what that device can do for physicians in their daily lives and workflow that drives its beloved brand status.
more...
MedTablet Expert's comment, November 20, 2011 5:30 PM
Tablets with EMRs or EHRs can lead to more unnecessary or nonevidence-based treatments, particularly in hospitals managed by so-called hospitalists. A hospitalist by definition is a physician contracted to maximizes hospital billing and collaborates on insurance funding. Instead of using the EMRs accessed in a tablet to refer to specialists like cardiologists and neurologists, a hospitalists will generate billing by connecting with other wellness type of providers. An example is PacificHospitalists.com contracted at Hoag Hospital in Newport Beach. When calling Pacific Hospitalists, their statement was the doctors do not work with patients but only with hospitals and insurance companies. My experience at Hoag was being billed for 45 chest X-rays by seven providers over 18 days despite no cardiac arrest, blockage, cholesterol or cardiomypathy. One provider stopped at 10 chest x-rays, and there were no reports of any physician actually reading the redundant chest X-rays. But the lead physician at Pacific Hospitalists did bill several thousand dollars for Day Encounters that supposed were to manage who did what with actual in-hospital services. Will physician tablets merely be a tool to connect for more unnecessary medical services? Insurance providers like UHC already disseminate patient records through outsourcers like inContact to telemarket hospital patients after returning home. Physician tablets with EMRs and EHRs could become social media for work-at-home nurses selling remote nursing, prescription management, and other wellness deals.
Thibaud Guymard's comment, November 20, 2011 5:57 PM
Thank you for sharing your experience. I hope it doesn't happen too often and it's not a common practice but, in any case, I think you should probably share your story with regulators.
Scooped by Thibaud Guymard
Scoop.it!

What in your view is the most significant obstacle to digital? Part II

What in your view is the most significant obstacle to digital? Part II | Digital Pharma | Scoop.it
This post concludes the list with a peek at the final three:

4. Social CRM
5. Analytics
6. Integration
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

FDA signals it will regulate medical apps

As more medical mobile applications get developed, one thorny question has arisen: Is there anyone who should be verifying whether these apps are effective and safe?

The question has come up, in particular, because of apps that claim to have a clinical component. They're a small part of the app universe, but experts expect clinical apps to hit the market in a big way over the next few years.

As it turns out, someone is already...
more...
No comment yet.
Scooped by Thibaud Guymard
Scoop.it!

Can web based services improve health outcomes?

Can web based services improve health outcomes? | Digital Pharma | Scoop.it
This month I was at an event hosted by HealthUnlocked, a UK company that develops web technology to support, engage and track patients with chronic diseases. The event’s aim was to present and launch the UK’s first online patient-reported outcome measures system called the HealthUnlocked Tracker.

Leading figures from health charities and the UK’s Secretary of State for Health, Andrew Lansley, were there to explain how HealthUnlocked’s online services could help shape clinical decisions in the NHS and help to put patients at the heart of the healthcare system.

Patients at the heart of Healthcare...
more...
No comment yet.